Boston Scientific Corp/ US1011371077 /
| 2024-04-17 9:59:59 PM | Chg. -0.15 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 67.95USD | -0.22% | 245,207 Turnover: 16.63 mill. |
-Bid Size: - | -Ask Size: - | 99.7 bill.USD | - | 62.93 |
Assets
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,564 | 1,546 | 1,507 | 1,490 | 1,630 | ||||||
| Intangible Assets | 6,289 | 5,950 | 5,606 | 6,194 | 5,883 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | 13,436 | 14,662 | 14,857 | ||||||
| Inventories | 884 | 897 | 946 | 1,016 | 955 | ||||||
| Accounts Receivable | - | - | 1,183 | 1,275 | 1,472 | ||||||
| Cash and Cash Equivalents | 207 | 217 | 587 | 319 | 196 | ||||||
| Current Assets | 3,022 | 3,011 | 3,606 | 3,471 | 3,239 | ||||||
| Total Assets | 17,154 | 16,571 | 17,042 | 18,133 | 18,096 | ||||||
Liabilities
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 232 | 246 | 262 | 209 | 447 | ||||||
| Long-term debt | - | - | 3,859 | 5,674 | 5,420 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 1,729 | 1,402 | 1,214 | 735 | 18 | ||||||
| Liabilities | 10,284 | 10,032 | 10,585 | 11,813 | 11,363 | ||||||
| Share Capital | - | - | 16 | 16 | 16 | ||||||
| Total Equity | 6,870 | 6,539 | 6,457 | 6,320 | 6,733 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 17,154 | 16,571 | 17,042 | 18,133 | 18,096 | ||||||
Income Statement
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7,249 | 7,143 | 7,380 | 7,477 | 8,386 | ||||||
| Depreciation (total) | 395 | 410 | 438 | 495 | 545 | ||||||
| Operating Result | -3,868 | 120 | -301 | -327 | 447 | ||||||
| Interest Income | -261 | -324 | -216 | -284 | -233 | ||||||
| Income Before Taxes | -4,107 | -223 | -509 | -650 | 177 | ||||||
| Income Taxes | -39 | -102 | -390 | -411 | -170 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -4,068 | -121 | -119 | -239 | 347 | ||||||
Per Share
Cash Flow
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,260 | 1,082 | 1,269 | 600 | 972 | ||||||
| Cash Flow from Investing Activities | -579 | -475 | -745 | -2,186 | -887 | ||||||
| Cash Flow from Financing | -744 | -596 | -150 | 1,322 | -206 | ||||||
| Decrease / Increase in Cash | -60 | 10 | 370 | -268 | -123 | ||||||
| Employees | 24,000 | 23,000 | 24,000 | 25,000 | 27,000 | ||||||
